Insights

Analysis & commentary

Perspectives on healthcare strategy, policy, and industry from the field.

Technical Jul 2026 8 min

We Re-Ran Our Own Benchmark. Here's What Broke, and What It Cost Us.

We found four confounds in our own MuSiQue benchmark program — input budgets, output provisioning, reasoning-policy semantics, reader-mode asymmetry. The corrected record includes the strongest result on our own harness belonging to the baseline. Full accounting, pre-registered predictions, and the public repo.

Analysis Jun 2026 15 min

The Quality Wall: Why RAG Retrieval Degrades Silently and What the Research Actually Shows

A synthesis of 31 peer-reviewed papers documenting twelve failure modes in RAG quality — why retrieval degrades at scale, why multi-hop breaks vector search, why hallucinations persist despite retrieval, and what the research says about fixing it.

Technical Jun 2026 14 min

The Deployment Mess: How RAG Became the Broken Link in Enterprise AI

Five databases. Five query languages. Five points of failure. The RAG infrastructure mess is why 72-80% of enterprise RAG implementations never reach production. Here's the architecture analysis, what stack collapse looks like, and benchmark data on a single-binary alternative.

Analysis May 2026 16 min

The Multi-Source Synthesis Problem in Healthcare AI: Is Multi-Hop Retrieval the Missing Key Piece?

AI saves lives when it looks at one thing. It struggles when it needs to connect multiple things. We trace the pattern, examine the successes, and identify the infrastructure gap.

Technical May 2026 18 min

RAG Needs to Start Adding Real Value

A February 2026 NBER study of 6,000 executives found over 80% of firms report no measurable productivity gains from AI. The problem isn't the models — it's what we're feeding them. We benchmarked our patent-pending retrieval engine on one of the hardest multi-hop QA benchmarks using the exact protocol and corpus of the leading academic system. Here are the results, the methodology, and the honest limitations.

Press Release Feb 2025 2 min

[Press Release] EluciDx Canada Ltd. and UBC Finalize Licensing Agreement for Oral Amphotericin B

Expanding global treatment options for systemic fungal infections and neglected tropical diseases through a dual-track development strategy.

White Paper Jan 2024 15 min

Regarding monoclonal antibody access initiatives for LMICs: A pragmatic and straightforward opinion

Why mAb product viability in low-income countries requires infrastructure investment — a CDMO-first model inspired by TSMC — before product development.

Analysis Mar 2021 17 min

A Case For The Perfect Healthcare System (for now)

Striking a careful balance is the only way to deliver sustainable healthcare. An examination of OECD data and a proposal for patent-expiry-pegged universal coverage.

Management Feb 2021 8 min

Employee Incentivization: Getting it so wrong is so easy

Incentives make society go 'round. Then why are so many employee incentivization schemes so dumb? A look at the disconnect between business objectives and HR.

Analysis Feb 2021 5 min

We have a definition problem in healthcare

Advances in healthcare research and technology are messing with traditional definitions of diseases used in practice. This is a ticking time bomb for public health.

Commentary Jan 2021 7 min

The Hubris of Equal Access in Healthcare

Everybody demands it immediately, but supply is limited because we live in a real world. COVID-19 proves it.

Analysis Jan 2021 10 min

The Messed-Up Value of Healthcare

The healthcare services market is 3x larger than tangible healthcare manufacturing sectors combined. What does this mean for how we value healthcare?

Analysis Jan 2021 8 min

Why aren't we tackling the asymptomatic spread of COVID-19 more aggressively?

The role of asymptomatic SARS-CoV-2 transmission in driving the pandemic and why our testing strategy needs a fundamental rethink.

Analysis Jan 2021 6 min

When the dust settles… (after COVID-19)

A look at what the post-pandemic healthcare landscape will look like and what lasting changes COVID-19 will leave behind.